| Ledinek A, Jazbec S, Drinovec I, et al.
Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report. [JOURNAL ARTICLE]
Mult Scler 2009 May 22.
Abstract | Full Citation | Find Related Articles |
| Carroll W
Clinical trials of multiple sclerosis therapies: improvements to demonstrate long-term patient benefit. [JOURNAL ARTICLE]
Mult Scler 2009 May 22.
Abstract | Full Citation | Find Related Articles |
| Nielsen JM, Pohl C, Polman CH, et al.
Prognostic implications of a carefully performed neurological assessment in patients with a first event suggestive of multiple sclerosis. [JOURNAL ARTICLE]
BMC Neurol 2009 May 20; 9(1):19.
Abstract | Full Citation |
| Castelli-Haley J, Oleen-Burkey MA, Lage MJ, et al.
Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis. [JOURNAL ARTICLE]
Adv Ther 2009 May 14.
Abstract | Full Citation |
| Lopategui Cabezas I, Cervantes Llano M, Pentón Rol G
[Optic neuromyelitis: Main differences with multiple sclerosis.] [English Abstract, Journal Article]
An Med Interna 2008 Jun; 25(6):294-6.
Abstract | Full Citation | Find Related Articles |
| Cadavid D, Wolansky LJ, Skurnick J, et al.
Efficacy of treatment of MS with IFN{beta}-1b or glatiramer acetate by monthly brain MRI in the BECOME study. [JOURNAL ARTICLE]
Neurology 2009 Mar 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Durelli L, Barbero P, Cucci A, et al.
Neutralizing antibodies in multiple sclerosis patients treated with 375 mug interferon-beta-1b. [JOURNAL ARTICLE]
Expert Opin Biol Ther 2009 Mar 11.
Abstract | Full Citation | Find Related Articles |
| Achiron A, Fredrikson S
Lessons from randomised direct comparative trials. [EDITORIAL]
J Neurol Sci 2009 Feb 1.:S19-S24.
Abstract | Full Citation |
| Eckermann S, Coory M, Willan AR
Indirect comparison: relative risk fallacies and odds solution. [JOURNAL ARTICLE]
J Clin Epidemiol 2009 Jan 27.
Abstract | Full Citation | Find Related Articles |
| Lazzaro C, Bianchi C, Peracino L, et al.
Economic evaluation of treating clinically isolated syndrome and subsequent multiple sclerosis with interferon beta-1b. [Journal Article, Research Support, Non-U.S. Gov't]
Neurol Sci 2009 Feb; 30(1):21-31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
